OTC · Financial Statements
IR-Med Inc. (IRME) Financial Statements
$0.00
OTC: IRME
Market Cap $84963
Overview Financials Dividend
IR-Med Inc. most recently reported annual revenue of $0, a net loss of $2.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2020 2021 2022 2023 2024
Revenue $0 $0 $0 $0 $0 Operating Profit $-1.0M $-4.0M $-5.0M $-5.0M $-2.0M Net Profit $-1.0M $-4.0M $-9.0M $-5.0M $-2.0M EPS $-0.03 $-0.06 $-0.14 $-0.07 $-0.03 Op Margin — — — — —
Balance Sheet (USD)
Metric 2020 2021 2022 2023 2024
Total Assets $2.0M $3.0M $3.0M $1.0M $0 Total Liabilities $1.0M $1.0M $1.0M $1.0M $1.0M Cash $2.0M $3.0M $3.0M $1.0M $0 Borrowings $0 $0 $0 $0 $0
Cash Flow (USD)
Metric 2020 2021 2022 2023 2024
Operating Cash Flow $0 $-2.0M $-3.0M $-3.0M $-1.0M Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $0 $0 $0 $1.0M $0 Net Cash Flow $2.0M $1.0M $0 $-2.0M $-1.0M Free Cash Flow $0 $-3.0M $-3.0M $-3.0M $-1.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.51 FCF Yield -213.03% Quick Ratio 0.12 Interest Coverage -0.58 Return 1Y -94.50% Return 3Y -99.91% Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .